Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability

mRNA疫苗poly(A)尾部的环状结构可提高抗原翻译效率和mRNA稳定性。

阅读:14
作者:Ayoung Oh # ,Seonghyun Lee # ,Hyeong-Jun Park # ,Subin Yoon ,Dahyeon Ha ,Jisun Lee ,Sowon Lee ,Gahyun Roh ,Youngran Cho ,Soo-Yeon Lee ,Eun-Jin Choi ,Yeeun Lee ,Seo-Hyeon Bae ,Seongje Cho ,Huijeong Choi ,Sohee Jo ,Jungmin Kim ,Hyo-Jung Park ,Jae-Hwan Nam

Abstract

As mRNA technology emerges as a groundbreaking innovation, an increasing number of studies are attempting to increase expression levels by optimizing the structure of mRNA, such as the 5' or 3' untranslated regions (UTR). We designed a novel loop structure in the poly(A) tail of an mRNA platform to improve the stability and duration. Protein expression analyses were conducted using bioluminescence, both in vitro and in vivo. Additionally, cellular and humoral responses to different antigens were confirmed using flow cytometry and ELISA of splenocytes and serum isolated from mice immunized with mRNA containing different poly(A) tail structures. The poly(A) tail with a loop structure exhibited higher bioluminescence signals, both in vitro and in vivo, and increased human erythropoietin (hEPO) expression in vivo compared to the other poly(A) tail groups. This indicates that the addition of a loop structure to the poly(A) tail region improves mRNA stability and efficiency. The results of analyzing cellular and humoral immunity by expressing HPV E6 and E7 antigens, and influenza virus HA antigens in mRNA with various poly(A) structures showed no significant difference in T cell immunity and antibody titer. In conclusion, the addition of stable structures, such as a loop to the poly(A) tail, can significantly increase the expression efficiency and stability of mRNA, but the expression difference did not have as much of an impact on the immune response as expected.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。